Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Burke Herbert Financial Services | BHRB | Nov 25, 2024 | 70.11 | +1.04 |
Burlington Stores | BURL | Nov 25, 2024 | 291.66 | +1.92 |
Burning Rock Biotech ADR | BNR | Nov 25, 2024 | 5.56 | -0.71 |
Burtech Acquisition A | BRKH | Nov 25, 2024 | 11.44 | +0.26 |
Business First Bancshares | BFST | Nov 25, 2024 | 28.95 | +2.01 |
Butterfly Network A | BFLY | Nov 25, 2024 | 3.28 | +1.23 |
Buyback Achievers Powershares | PKW | Nov 25, 2024 | 124.44 | +0.56 |
BuzzFeed A | BZFD | Nov 25, 2024 | 4.24 | +12.47 |
BV Financial | BVFL | Nov 25, 2024 | 16.91 | +0.77 |
BW LPG | BWLP | Nov 25, 2024 | 13.11 | -3.25 |
BWX Technologies | BWXT | Nov 25, 2024 | 130.39 | -1.88 |
Byline Bancorp | BY | Nov 25, 2024 | 32.04 | +0.31 |
byNordic Acquisition A | BYNO | Nov 25, 2024 | 11.43 | 0.00 |
Byrna Technologies | BYRN | Nov 25, 2024 | 19.99 | -6.19 |
C&F Financial | CFFI | Nov 25, 2024 | 76.82 | +3.55 |
C.H. Robinson Worldwide | CHRW | Nov 25, 2024 | 107.54 | -0.07 |
C3.ai | AI | Nov 25, 2024 | 37.86 | +1.18 |
C3is | CISS | Nov 25, 2024 | 0.84 | -0.73 |
C4 Therapeutics | CCCC | Nov 25, 2024 | 4.38 | +3.06 |
Cabaletta Bio | CABA | Nov 25, 2024 | 2.29 | +22.46 |
Cabana Target Drawdown 10 ETF | TDSC | Nov 25, 2024 | 25.88 | -0.05 |
Cabana Target Drawdown 7 ETF | TDSB | Nov 25, 2024 | 22.79 | +0.35 |
Cable One | CABO | Nov 25, 2024 | 425.99 | +2.27 |
Cabot | CBT | Nov 25, 2024 | 113.55 | +2.89 |
CACI International A | CACI | Nov 25, 2024 | 464.35 | -0.95 |
Cactus A | WHD | Nov 25, 2024 | 69.49 | +0.72 |
Cactus Acquisition 1 A | CCTS | Nov 25, 2024 | 11.65 | 0.00 |
Cadeler ADR | CDLR | Nov 25, 2024 | 23.96 | +0.34 |
Cadence Bank | CADE | Nov 25, 2024 | 39.29 | +1.05 |
Cadence Bank A | CADE-A | Nov 25, 2024 | 21.20 | +1.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.